U.S. Oil and Gas Stock News

Altria Group stock has delivered a strong 134.4% return over the past 5 years, and the latest intrinsic value checks using a Discounted Cash Flow (DCF) approach currently point to the shares trading at a discount of 43.7% to that estimate. Over 5 years Altria Group has returned 134.4%, which puts current valuation in focus after a solid period for long term holders. Recent FDA proposals that may tighten oversight of foreign tobacco manufacturers can support Altria Group's pricing power,...

Clean Harbors, Inc. has reported its second-quarter 2026 results, with sales of US$1,735.01 million and net income of US$170.46 million, alongside higher basic and diluted earnings per share from continuing operations compared with the same period in 2025. These stronger earnings figures, together with recently completed board leadership changes following founder Alan S. McKim’s retirement, highlight both improved profitability and an evolving governance framework for the environmental and...

Accenture stock reaction to buyback, dividend and AI partnerships Accenture (ACN) recently drew investor attention after announcing a new US$2b share repurchase program and a fresh quarterly dividend, alongside quarterly earnings that exceeded expectations and new AI partnerships. The company has also been active on the client side, including an AI powered hotel discovery app with Radisson Hotel Group and expanded AI work with Google Cloud. This activity keeps Accenture in focus for investors...

Advanced Micro Devices (NasdaqGS:AMD) has entered a 15-year AI data center agreement with Core Scientific valued at over $14b. The partnership gives AMD access to up to 2.5 gigawatts of AI data center capacity across multiple U.S. locations. Initial deployment of around 530 megawatts is planned across five states starting in 2027 to host Instinct GPUs and EPYC CPUs. The deal supports AMD's AI product rollout and aligns with Core Scientific's shift toward AI infrastructure hosting. Advanced...

Valero Energy stock has delivered a very large 446.0% return over the past five years, yet the valuation signals are pulling in different directions as the Discounted Cash Flow (DCF) estimate points to significant upside while market multiples lean expensive. Over five years, Valero Energy has returned 446.0%, which puts recent pricing in sharp focus for anyone considering what is already embedded in the share price. Direct access to Venezuelan crude, as refiners increasingly contract with...

Sensata Technologies Holding plc recently reported past second-quarter 2026 results showing sales of US$990.6 million and net income of US$102.1 million, with basic earnings per share from continuing operations rising to US$0.70 from US$0.41 a year earlier. Alongside these stronger earnings, Sensata confirmed a US$0.12 per-share quarterly dividend and completed a US$242.72 million buyback covering 7,667,332 shares, underlining its ongoing capital return program. With this improved...

Kinetik Holdings recently faced softer expectations for its June 2026 quarter, with analysts projecting a year-over-year decline in both earnings and revenue alongside a negative Earnings ESP. This shift in analyst estimates highlights mounting concern about near-term operational performance and how the company’s upcoming results may challenge prior assumptions. We’ll now examine how weaker expected quarterly earnings and a more cautious analyst stance could reshape Kinetik Holdings’ broader...

Why SL Green Realty’s latest quarter is drawing investor attention SL Green Realty (SLG) is back in focus after reporting second quarter 2026 funds from operations of $1.43 per share, ahead of expectations, alongside higher net rental revenue and better performance in its Manhattan portfolio. See our latest analysis for SL Green Realty. At a share price of US$53.82, SL Green Realty has seen a 26.9% 90 day share price return and a 14.61% year to date share price return, while the 3 year total...

LCI Industries (LCII) stock is drawing attention after the company expanded its Board to seven directors and appointed Robert P. Hureau on July 18, 2026, with committee roles across key oversight areas. See our latest analysis for LCI Industries. Against this board refresh, LCI Industries’ share price has moved to US$106.55, with a 30 day share price return of 6.42% and a 90 day share price decline of 10.63%. The 1 year total shareholder return of 15.07% contrasts with weaker multi year...

Arbutus Biopharma and Genevant Sciences have launched new patent lawsuits targeting lipid nanoparticle technology used in Pfizer BioNTech (NasdaqGS:BNTX) COVID-19 vaccines. The actions seek monetary damages and potential injunctions across Canada and multiple European countries. See our latest analysis for BioNTech. For investors, the latest lawsuits arrive after a weaker period for BioNTech’s stock, with the share price at US$92.95 and short term momentum softening following a 90 day share...

Archer Aviation stock has fallen sharply over the past year, yet on simple market multiples it still screens as undervalued, leaving investors weighing weak recent returns against a mixed but not outright negative valuation picture. Archer Aviation shares are down 55.9% over the past year, which signals that sentiment around the stock has been under pressure even as news flow has been active. The new autonomous aircraft platforms with Anduril and the infrastructure push under the ACES...

Earlier this week, UDR, Inc. raised its full-year 2026 net income guidance to a range of US$1.03 to US$1.11 per diluted share, up from its prior US$0.91 to US$1.01 range, and projected third-quarter 2026 net income of US$0.13 to US$0.15 per diluted share. The guidance increase followed stronger-than-expected second-quarter performance, underpinned by solid occupancy, record resident retention, ongoing share repurchases, and new development activity amid a reshaping of its debt and asset...

In recent weeks, U.S. Bancorp completed a series of fixed‑income offerings totaling several billion US$, issued mainly as callable senior unsecured notes with fixed coupons ranging from 5.05% to 6.15% and fixed‑to‑floating structures maturing between 2030 and 2046. Alongside these bond sales, the bank reported higher second‑quarter net interest income and net income year over year, raised its 2026 revenue guidance, and continued share repurchases, underscoring management’s confidence while...

Procter & Gamble’s latest results have put fresh attention on how higher costs and softer volumes can affect even the largest consumer goods companies. Revenue came in at $21.2b, slightly below expectations, and management flagged a $1b after tax cost headwind and an estimated 8% drag on 2027 earnings guidance. For you as an investor, that kind of update can shift attention toward businesses that focus on private label and value products. This article looks at three stocks that appear exposed...

Watsco, Inc. reported its Q2 2026 results with sales rising to US$2,104.86 million from US$2,062.44 million a year earlier, while net income declined to US$163.34 million from US$183.61 million and diluted EPS from continuing operations eased to US$4 from US$4.52. Alongside the mixed earnings, Watsco announced the acquisition of Jackson Supply Company, broadening its Sunbelt footprint as it continues investing in e-commerce, technology, and AI-driven tools to improve efficiency in the...

FirstEnergy stock slipped about 1% today, a muted reaction for a regulated utility that has been trading near the upper end of its recent range. The move understates the real tension in this quarter. The headline is not revenue or earnings per share; it is pressure on profitability at a time when investors already question how comfortably this balance sheet supports a premium P/E and a dividend that is not well covered by earnings. Q2 core earnings per share landed at about 50 cents and net...

Core Scientific entered this earnings report with a high growth story and a stock that had already been under pressure over the past month. The market’s initial reaction was clear, with the share price falling 12.65% to US$18.12 in regular trading after the results. The main headline is not revenue, which came in at US$164.2 million for the quarter. The focus is on the size of the loss. Core Scientific reported net income from ongoing operations excluding extra items of US$1.08b in the red...

Western New England Bancorp came into this earnings season with a reputation as a slow and steady regional lender, yet the stock just dropped roughly 12% in a single session. That is a sharp move for a community bank that has been posting solid trailing profit margins. The headline this quarter is pressure on profitability. Quarterly basic earnings per share landed at US$0.18 on revenue of US$21.16m, both lower than recent runs, which jarred a market that had been treating the stock as a...

Vertex Pharmaceuticals stock reaction to new AbCellera collaboration Vertex Pharmaceuticals (VRTX) drew fresh attention after AbCellera Biologics announced a collaboration to develop multispecific T cell engagers for autoimmune diseases. Under the agreement, Vertex will fund research and retain rights to advance and commercialize the resulting therapies. See our latest analysis for Vertex Pharmaceuticals. For context, Vertex Pharmaceuticals shares are at US$483.33, with a 90 day share price...

Delek US Holdings stock has turned a US$1 investment five years ago into roughly US$4 today, yet the company still screens as cheap on Simply Wall St’s valuation checks. After such a strong run, investors are weighing whether the recent share price strength has already captured that value gap or if there is still room based on fundamentals. Over the past 5 years, Delek US Holdings has delivered a very large total return of about 359.7%, which puts the current share price into sharper focus...

Atlantic Union Bankshares (AUB) is back on investor radar after reporting sharply higher net income and earnings per share for the second quarter and first half of 2026, alongside active capital return moves. See our latest analysis for Atlantic Union Bankshares. At a share price of $42.62, Atlantic Union Bankshares has a 90 day share price return of 13.2% and a 1 year total shareholder return of 37.82%. This suggests momentum has been building as investors respond to stronger earnings,...

JetBlue Airways has returned 27.4% over the past year and is up 24.6% year to date, yet over five years the stock is still down 60.5%. This leaves many investors asking whether the current price around US$5.72 reflects a genuine turnaround or just a rebound from a much lower base. At the same time, Simply Wall St's valuation checks point to JetBlue screening as undervalued on the broader metrics, even as recent headlines highlight both progress and ongoing pressure on profitability. Over the...

Humana stock has delivered a strong 41.8% return over the past year, yet its valuation checks and market multiples point to a more mixed picture rather than a straightforward bargain or bubble. Over the last 12 months, Humana has returned 41.8%, which puts recent share price weakness into context for investors assessing whether the move has already priced in a lot of good news. Humana's valuation can be influenced by how consistently it converts revenue into cash flow, while any sustained...

Summit Therapeutics has reported a reduced net loss for the second quarter of 2026 and filed for a US$380 million at-the-market equity offering, while also highlighting updated overall survival data from its Phase III HARMONi trial of ivonescimab and entering a new kidney cancer trial collaboration with Arcus Biosciences. The combination of encouraging HARMONi survival trends, an expanded clinical footprint into metastatic kidney cancer, and fresh equity financing underscores how central...